Floatz logo

Immunoglobulin G1 [143-aspartic acid,236-glutamic acid], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal HBM4003 heavy chain V-D-J region) fusion protein with immunoglobulin G1 (human ?1-chain C region), dimer

Advanced Solid Tumor

Harbour BioMed US, Inc.monoclonal_antibodyPhase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
59/ 100

Competitive context

1412 Active assets in the Advanced Solid Tumor cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
Inno-206
M.D. Anderson Cancer Center
Phase 2BB
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
PROPOFOL
Hong Kong Children's Hospital
Phase 4BB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1 [143-aspartic acid,236-glutamic acid], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal HBM4003 heavy chain V-D-J region) fusion protein with immunoglobulin G1 (human ?1-chain C region), dimer is also rated in:

colorectal cancerDormant
CC
Indicative ·
41 / 100
View asset →
neuroendocrine neoplasmDormant
C
Indicative ·
39 / 100
View asset →
neoplasmDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →